Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01963104 · ClinicalTrials.gov registry record · NA

Community-Based Kiosks for Hearing Screening and Education

A NA study of Hearing Loss, sponsored by Portland VA Medical Center.

Completed
Registry status
NA
Development phase
2,048
Enrollment target
4
Study locations

NCT01963104: Completed NA study of Hearing Loss, sponsored by Portland VA Medical Center.

NCT01963104 is a NA study of Hearing Loss that has completed, run by Portland VA Medical Center. The registered enrollment target is 2,048 participants, below the 6,086-participant average among 58 other Hearing Loss trials with a reported enrollment target (66% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01963104, a NA study of Hearing Loss, has completed, sponsored by Portland VA Medical Center.

COMPLETED
Registry status
NA
Development phase
2,048 participants
Enrollment target
4
Study locations

Study Summary

The overall goal of the project is to evaluate innovative, cost-effective, community-based automated hearing screening and education methods to motivate individuals with mild-to-moderate hearing loss to enter the hearing healthcare system.

Conditions Studied

Interventions

  • PROCEDURE Automated hearing test
  • PROCEDURE Pure-tone Screener test
  • PROCEDURE Digits-in-noise test
  • PROCEDURE No screening test
  • PROCEDURE Automated hearing test/Motivation video

Study Locations (4)

Florida

  • Bay Pines VAHCS - Bay Pines

Minnesota

  • University of Minnesota - Minneapolis

Ohio

  • Ohio State University - Columbus

Oregon

  • Portland VA Medical Center, National Center for Rehabilitative Auditory Research - Portland

Trial Details

FieldValue
Enrollment Target 2,048 participants
Start Date 2013-09
Est. Completion 2019-07
Phase NA
Portland VA Medical Center

15 total trials

What the finished NCT01963104 record still lists

NCT01963104 is an interventional study that assigns participants to a tested intervention. Its 2,048 participants enrollment target places it among the larger protocols in the corpus, below the 6,086-participant average among 58 other Hearing Loss trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 5 interventions - of which Automated hearing test is the first listed.

NCT01963104 reports a single indexed study location in Florida, Minnesota, Ohio.

Frequently Asked Questions

What is clinical trial NCT01963104 about?

NCT01963104 is a clinical study titled "Community-Based Kiosks for Hearing Screening and Education". The overall goal of the project is to evaluate innovative, cost-effective, community-based automated hearing screening and education methods to motivate individuals with mild-to-moderate hearing loss to enter the hearing healthcare system.

What is the current status of trial NCT01963104?

This trial is currently completed. It is a NA study. The enrollment target is 2,048 participants. The study started on 2013-09. Estimated completion is 2019-07.

What conditions does trial NCT01963104 study?

This clinical trial studies the following conditions: Hearing Loss.

What interventions are being tested in trial NCT01963104?

The interventions under investigation include: Automated hearing test (PROCEDURE), Pure-tone Screener test (PROCEDURE), Digits-in-noise test (PROCEDURE), No screening test (PROCEDURE), Automated hearing test/Motivation video (PROCEDURE).

Who is sponsoring clinical trial NCT01963104?

This trial is sponsored by Portland VA Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01963104 being conducted?

This trial has 4 study locations across Florida, Minnesota, Ohio, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01963104's enrollment target sits among peer trials

2,048 5th of 58 higher than 54 of 58 other Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05688982 · 2,049 participants · NA

    MOLAR: Mapping Oral Health and Local Area Resources

  • NCT05050084 · 2,050 participants · Phase 3

    Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

  • NCT06833476 · 2,044 participants

    TTVR STRONG Under Coverage With Evidence Development (CED) Study

  • NCT05138718 · 2,041 participants

    FDG an Myocardial Infarction: The PIAF Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01963104, the US trial registry maintained by the National Library of Medicine. NCT01963104 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.